PRESENTATIONS
authorized documents
Keynote lecture
Fayza DABOUSSI, Director Life Sciences at Toulouse White Biotechnology (TWB), France
SESSION 1 – INDUSTRIAL BIOPRODUCTION STRATEGIES, Part 1
Michael J. O’DONOHUE, INRAe
IBISBA: integrating European capacity in industrial biotechnology
John McBRIDE, Vice President for R&D at Mascoma LLC/Lallemand, Darmouth College, USA
New Yeasts for fuel ethanol production
Anthony BRESIN, Chief Technology Officer, HTL Biotechnology, France
Constraints associated to the development of a novel polysaccharide by fermentation
FLASH POSTERS PRESENTATION
Marc BRUYNINX, Twist Bioscience
SESSION 1 (continued) – INDUSTRIAL STRATEGIES, Part 2
Frank DELVIGNE, Professor, University of Liège, Belgium
Scale-up of microbial processes: a modern light on an old issue
Simon TRANCART, Altar
Unlocking the potential of industrial biotechnology with adaptative evolution
Leonardo MAGNESCHI, Section Head – Molecular Biology, Ingenza Ltd., Scotland
SynBio A to Z: integrated bioengineering platforms for efficient biomanufacturing in prokaryotic and eukaryotic production systems
Jan-Willem de GIER, Professor, Stockholm University, Sweden
Engineering E. coli strains for recombinant Protein production
Egon HEUSON, Ecole Centrale de Lille, France
High-throughput strain identification and production of fungal enzymatic cocktails for the valorisation of lignocellulosic biomass
Guy HELIN, Syngulon, Belgium
Taking a license on CRISPR/Cas9: a testimony
SESSION 2 – INDUSTRY-SCALE FERMENTATION
Nico SNOECK, Bio Base Europe Pilot Plant, Belgium
Challenges in scale-up of industrial bioprocesses
Sophie ROELANTS, BBE, University of Ghent, Belgium
Metabolic engineering for the production of specialty carbohydrates and biosurfactants
Lorie HAMELIN, TBI /INSA (Toulouse Biotechnology Institute)/Federal University Toulouse (France)
Role of industrial biotech within a sustainable national strategy towards zero fossil carbon
FLASH POSTERS PRESENTATION
Emeraude HADJ-ATTOU, Microsynth
SESSION 3 – EXPRESSION SYSTEMS FOR THERAPEUTIC PROTEINS
Mathieu ROCABOY, Scientific advisor, Xpress Biologics, Belgium
A molecular biology Toolbox for rapid selection of E. coli expression strains
Lena THORING, FyoniBio
GlycoExpress® – an alternative host for difficult to express proteins
Esteban LEBRUN, Sanofi, France
An in-droplet assay for the functional selection of antibodies from yeast libraries
Muriel BARDOR, Université de Rouen, France
Microalgae as alternative cell factory for the production of monoclonal antibodies
SESSION 4 – MODELING and EMERGING APPROCHES
Moritz VON STOSCH, DataHow AG, Switzerland
Hybrid modeling, combining data- and knowledge-driven modeling for fast and systematic upstream process development
Thanos BEOPOULOS, Bio-Modeling Systems
CADI™ Heuristic Modeling for Complete & Efficient Human Protein Glycosylation in Yeast
